Julia Foldi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Neoadjuvant Chemotherapy

Endoplasmic Reticulum

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Research square

NPJ breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M Da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. bioRxiv : the preprint server for biology (2024)
Julia Foldi, Kim R M Blenman, Michał Marczyk, Vignesh Gunasekharan, Alicja Polanska, Renelle Gee, Mya Davis, Adriana M Kahn, Andrea Silber, Lajos Pusztai
Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer. Breast cancer research and treatment (2024)
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M Da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M Da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Fangyuan Chen, Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore, Sai Maley, George C Tseng, Peter Lucas, Tullia Bruno, Dario Vignali, Julia Foldi, Marija Balic, Adrian V Lee, Steffi Oesterreich
Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast Cancer. Research square (2024)
Fangyuan Chen, Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore, Sai Maley, George C Tseng, Peter Lucas, Tullia Bruno, Dario Vignali, Julia Foldi, Marija Balic, Adrian V Lee, Steffi Oesterreich
Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast Cancer. Research square (2024)
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M Da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. Proceedings of the National Academy of Sciences of the United States of America 121 (31) (2024)
Osama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, Jennifer M Atkinson, Celina G Kleer, Priscilla F McAuliffe, Tyler J Johnston, Wayne Stallaert, Edaise M da Silva, Pier Selenica, Higinio Dopeso, Fresia Pareja, Diana Mandelker, Britta Weigelt, Jorge S Reis-Filho, Rohit Bhargava, Peter C Lucas, Adrian V Lee, Steffi Oesterreich
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutations. bioRxiv : the preprint server for biology (2024)
Fangyuan Chen, Sayali Onkar, Jian Zou, Yujia Li, Haley Arbore, Sai Maley, George C Tseng, Peter Lucas, Tullia Bruno, Dario Vignali, Julia Foldi, Marija Balic, Adrian V Lee, Steffi Oesterreich
Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast Cancer. Research square (2024)
Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A Schnabel, Adam Brufsky, G J van Londen, Lajos Pusztai, Tara Sanft
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer. BMC cancer 23 (1) (2023)
Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A Schnabel, Adam Brufsky, G J van Londen, Lajos Pusztai, Tara Sanft
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer. BMC cancer 23 (1) (2023)
Julia Foldi, Anastasia Tsagianni, Max Salganik, Catherine A Schnabel, Adam Brufsky, G J van Londen, Lajos Pusztai, Tara Sanft
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer. BMC cancer 23 (1) (2023)
Julia Foldi, Adriana M Kahn, Andrea L M Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Adam Blanchard, Kim R M Blenman, David L Rimm, Lajos Pusztai
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Ngozi D Akingbesote, Aaron Norman, Wanling Zhu, Alexandra A Halberstam, Xinyi Zhang, Julia Foldi, Maryam B Lustberg, Rachel J Perry
A precision medicine approach to metabolic therapy for breast cancer in mice. Communications biology 5 (1) (2022)
Michał Marczyk, Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal, Naing Lin Shan, Kim R M Blenman, Tess A O'Meara, Sheila Umlauf, Yulia V Surovtseva, Viswanathan Muthusamy, Jesse Rinehart, Rachel J Perry, Richard Kibbey, Christos Hatzis, Lajos Pusztai
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer. Cancer research 82 (9) (2022)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 8 (1) (2022)
Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim R M Blenman, Uwe Holtrich, Kevin M Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 8 (1) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea L M Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Julia Foldi, Andrea Silber, Emily S Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michał Marczyk, Courtney Frederick, Trisha Burrello, Eiman Y Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L Rimm, Lajos Pusztai
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer. NPJ breast cancer 7 (1) (2021)